Working toward a life less interrupted for people with IC/BPS.
Living with interstitial cystitis and bladder pain syndrome (IC/BPS) can be debilitating, but Ironwood is sponsoring a clinical research study of a new potential treatment that could offer relief. The IC/BPS Clinical Study will evaluate an investigational, foam-based drug designed to inhibit pain receptors in the colon, which may modify pain in the bladder.
Many of the 4 to 12 million people in the U.S. with IC/BPS may be interested in a new option for pain management as they have been unable to find relief from the discomfort and life interruption associated with the disease. This is why we’re conducting the IC/BPS Clinical Study.
What is IC/BPS?
IC/BPS is a chronic condition with symptoms of increased urinary urgency and frequency, nighttime urination, bladder pressure and severe pelvic pain. Pain and symptoms experienced due to IC/BPS can make daily life difficult and painful and may be so severe that they can negatively impact a person’s quality of life.
In an effort to develop a safe, dedicated, potential pain management option to relieve IC/BPS pain, Ironwood is conducting a phase 2 clinical trial of a novel, rectally administered foam. The study drug is designed to utilize the shared nerve pathways between the colon and bladder to modify pain signals in the colon, which might also relieve bladder pain associated with IC/BPS.
IC/BPS Clinical Study at a Glance
- Participants: 50+
- Duration: 12 weeks (not including screening)
- Administration: Orally once daily at Bedtime
- Study Groups: This is a “Cross-over” study design where all patients will have the opportunity receive both study drug and placebo at different time during the study period.
To participate in this study, you must meet these criteria*:
- Adult between the ages of 18 and older
- Your doctor has diagnosed you with Interstitial Cystitis /Bladder Pain Syndrome or indicated that your symptoms meets criteria for IC/BPS as defined by the American Urology Association which “an unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, accompanied by urinary frequency or urgency which have persisted for more than six weeks
- You have undergone evaluation to rule out other causes of bladder pain/discomfort.
*Other criteria will apply.
| While participating in the study, you’ll receive either the investigational drug or a matching placebo at different times during the 12 study period, study-related care and monitoring of your IC/BPS symptoms and compensation for travel and expenses related to study participation, if needed. |
To learn more and find out if you may be eligible,
please visit icbpsclinicalstudy.com
Study Locations:
(*indicates a center will open soon)
Arizona Locations
- Tucson, Arizona, United States, 85715 – Urological Associates of Southern Arizona
Arkansas Locations
- Little Rock, Arkansas United States 72212 – Applied Research Center of Arkansas
California Locations
- Los Angeles, California, United States, 91303 – Hope Clinical Research LLC
- Los Angeles, California, United States, 90017 – Urology Group of Southern California
- Murrieta, California, United States – TriValley Urology Medical Group
Georgia Locations
- Decatur, Georgia, United States – Accel Research Site – Neurostudies
Illinois Locations
- Evergreen Park, Illinois – Provides Health Partners LLC
Louisiana Locations
- Metairie, Louisiana, United States, 70121 – Southern Clinical Research Associates
- Shreveport, Louisiana, United States 71106 – Regional Urology LLC
Massachusetts Locations
- Watertown, Massachusetts, United States, 02472 – Bay State Clinical Trials
Michigan Locations
- Dearborn Heights, Michigan, United States, 48073 – Revive Research Institute
New York Locations
- Garden City, New York, United States, 11530 – Accumed Research Associates
North Carolina Locations
- Winston-Salem, North Carolina, United States, 27103 – Unified Women’s Clinical Research, Lyndhurst Clinical Research
Ohio Locations
- Cleveland OH, United States 44109 – Metro Health System
